Piper Sandler analyst Nathan Race maintains 1st Source (NASDAQ:SRCE) with a Overweight and lowers the price target from $64 to $58.
Analyzing Eli Lilly and Co In Comparison To Competitors In Pharmaceuticals Industry
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors…